Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07384013
NA
Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs
Sponsor: Rambam Health Care Campus
View on ClinicalTrials.gov
Summary
Evaluation of the Effect of metamizole (Optalgin®) on Anti-Xa Levels in Oncology Patients Receiving Direct Oral Anticoagulants (DOACs)
Official title: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-11-01
Completion Date
2027-12-31
Last Updated
2026-02-03
Healthy Volunteers
No
Interventions
DRUG
metamizole
chronic metamizole use
DRUG
metamizole
New metamizole users
Locations (1)
Rambam Health Care Campus
Haifa, Israel